CFTR and cystic fibrosis: The use of personalized models such as this also have the potential to advance understanding of CF-related disease mechanisms by identifying phenotypic variability to drug response in patients with the same CFTR mutation as well as facilitating the development of cost-effective approaches for selecting efficacious drug regimens for CF patients.